CYTK  valuation analysis

Name: Cytokinetics, Incorporated
Description: Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $1.38B (1167th)
Sales(TTM): $58.55M (1405th)
Earnings(TTM): -$87.93M (1254th)

FFER: 2.42 (why)
Actual price: $19.32
FFEThis is Cytokinetics, Incorporated's the estimated price. FFEs are the denominator of the FFER ratio.: $7.98
Quantile: CYTK is very expensive given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Cytokinetics, Incorporated
"Biotechnology" industry
Sales / MarketCap
Cytokinetics, Incorporated
"Biotechnology" industry
Book / MarketCap
Cytokinetics, Incorporated
"Biotechnology" industry
Equity / Assets
Cytokinetics, Incorporated
"Biotechnology" industry